On 10 June 2025, the “Sino-UK Pharmaceutical Cooperation Partnering Conference” convened at the Millennium Gloucester Hotel in London, providing a valuable forum for professionals and organisations from both the UK and China to explore new opportunities in life sciences and healthcare innovation. Hosted by China Medical City (CMC) of Taizhou, the event welcomed a diverse group of government representatives, industry experts, and innovative enterprises to share knowledge and discuss practical avenues for collaboration.
Highlights and Professional Exchange
The conference opened with remarks from leaders of the Taizhou Medical High-Tech Zone, who spoke about CMC’s growth as a centre for life sciences and its commitment to supporting international partnerships. Ding Mingqin, Science and Technology Counsellor from the Chinese Embassy, also addressed attendees, expressing support for ongoing professional exchange and cooperation in the pharmaceutical sector.
Presentations from CMC highlighted the zone’s industrial strengths, innovation resources, and regulatory support, illustrating its role in enabling international business and research connections. UK participants—including MedCity, the University of Southampton’s Medical Technology Innovation Centre, and several biotech companies—offered perspectives on the UK’s vibrant life sciences ecosystem and discussed potential areas for joint development, such as precision medicine, AI-driven healthcare, and enterprise incubation.
New Partnerships and Collaborative Initiatives
A key outcome of the event was the signing of cooperation agreements between China Medical City and UK-based pharmaceutical innovation projects. These agreements are designed to foster practical collaboration in regulatory affairs, business incubation, and healthcare technology, helping organisations from both countries access new markets and resources.
EFEC’s Role: Supporting Cross-Border Innovation
Excellence First Enterprise Consultancy Ltd (EFEC), represented by CEO Lily Lin, Chief Scientific Officer Professor Graham Ball, and our Associate Advisor Bob Roopra, participated as invited guests and facilitators. EFEC continues to support connections between the UK and Chinese life sciences sectors, providing strategic, cultural, and operational guidance for UK companies entering China and for Chinese enterprises seeking to establish a presence in the UK.
EFEC’s services include partnership development, market entry, and localisation strategies, helping organisations navigate the practical aspects of international collaboration. By leveraging networks in regions such as Cambridge and the Midlands, EFEC aims to facilitate efficient connections and support the long-term growth of innovative projects.
Looking Ahead: Opportunities for Collaboration
With new agreements in place and ongoing dialogue, both UK and Chinese stakeholders are well-positioned to pursue further cooperation in areas such as:
- Joint research and development in precision medicine and digital health
- Sharing best practices in regulatory compliance and market access
- Supporting enterprise incubation and commercialisation initiatives
The London forum demonstrated the value of professional exchange and practical partnership in advancing healthcare innovation. As organisations continue to collaborate, there is strong potential for mutually beneficial outcomes that will contribute to the growth and global impact of the life sciences sector in both countries.